Real‐world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA ( EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real‐life clinical practice) study

Drug Survival of Adalimumab, Ustekinumab, and Secukinumab in Patients with Psoriasis: a Prospective Cohort Study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

(2020) Z.Z.N. Yiu et al.   BRITISH JOURNAL OF DERMATOLOGY

Real‐world evidence of secukinumab in psoriasis treatment – a meta‐analysis of 43 studies

(2020) M. Augustin et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2‐year period

(2020) M. Megna et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO‐BIO‐REAL)

(2020) J. Seneschal et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real‐world evidence study

(2020) J.F.B. Schwensen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Secukinumab Drug Survival in Patients with Psoriasis: A multicenter, real-world, retrospective study

(2019) Tiago Torres et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

(2019) Matteo Megna et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Real world data from the use of secukinumab in the treatment of moderate‐to‐severe psoriasis, including scalp and palmoplantar psoriasis: A 104‐week clinical study

(2019) Natalia Rompoti et al.   Dermatologic Therapy

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

(2019) Andrea Chiricozzi et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Comparison of Real-World Treatment Patterns among Psoriasis Patients Prescribed Ixekizumab or Secukinumab

(2019) Andrew Blauvelt et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis

(2019) Marco Galluzzo et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review

(2018) Aleksandra G. Florek et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16,545 biologic-naïve patients from the French national health insurance database (SNIIRAM)

(2018) E. Sbidian et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity

(2018) Mwangi J. Murage et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis

(2018) Jawad Bilal et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

(2018) Farzad Alinaghi et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review

(2018) Francesca Prignano et al.   Current Rheumatology Reports

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

(2018) Pei-Tzu Lin et al.   Scientific Reports

Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response

(2018) L.M. Sawyer et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis

(2017) Jillian Frieder et al.   Expert Review of Clinical Immunology

Epigenetics of psoriatic disease: A systematic review and critical appraisal

(2017) Remy A. Pollock et al.   JOURNAL OF AUTOIMMUNITY

PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis

(2017) Carlo Giovanni Carrera et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Drug survival of biologic treatments in psoriasis: a systematic review

(2017) Daniel J. No et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis

(2017) Zarif K. Jabbar-Lopez et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Real-world burden of comorbidities in US patients with psoriasis

(2017) Kamal Shah et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Psoriasis and comorbid diseases

(2017) Junko Takeshita et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

(2017) Andrew Blauvelt et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study

(2017) A. Körber et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

(2016) Bruce E. Strober et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

A systematic review of worldwide epidemiology of psoriasis

(2016) I.M. Michalek et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Treatment Satisfaction of Patients with Psoriasis

(2015) M Schaarschmidt et al.   ACTA DERMATO-VENEREOLOGICA

Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis

(2015) Axel Patrice Villani et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

(2012) Rosa Parisi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Definition of treatment goals for moderate to severe psoriasis: a European consensus

(2010) U. Mrowietz et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results

(2008) M.K.A. Basra et al.   BRITISH JOURNAL OF DERMATOLOGY

Regional distribution of psoriasis in Italy

(2007) R Saraceno et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY